Under pathological conditions, such as post-ischemic reperfusion injury (Hara et al., 2002; Kaneko et al., 2006) and potentially in Alzheimer's disease (Fonfria et al., 2005), TRPM2 activity leads to Ca2+ dysregulation and cell death. This evidence concerns the gene TRPM2 and Alzheimer disease.